Screenshot 2023-07-02 143440.jpg
Fortrea, 임상시험 수행작업 향상 목표로 기술 및 인적 솔루션 더욱 강화하기 위해 AI 혁신 스튜디오 전격 출범
June 28, 2024 10:08 ET | Fortrea Holdings Inc
노스캐롤라이나 더럼, June 28, 2024 (GLOBE NEWSWIRE) --  글로벌 임상시험수탁기관(CRO)인 포트리아(Fortrea, 나스닥 FTRE)가 인공지능 혁신 스튜디오 (AI Innovation Studio)를 출범한다고 오늘 발표하면서 현재 그리고 미래에 추진될 임상시험 시행 방식의 재편을 위한 전략적 투자 의지를 시사했다. AI...
Screenshot 2023-07-02 143440.jpg
Fortrea lance un studio d’innovation en IA pour galvaniser les solutions technologiques et humaines afin d’améliorer la réalisation des essais cliniques
June 28, 2024 10:08 ET | Fortrea Holdings Inc
DURHAM, État de Caroline du Nord, 28 juin 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a annoncé...
Fortrea Logo.jpg
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
June 27, 2024 07:00 ET | Fortrea Holdings Inc
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI)...
Fortrea Logo.jpg
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
June 19, 2024 17:02 ET | Fortrea Holdings Inc
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will...
Screenshot 2023-07-02 143440.jpg
Fortrea finaliza desinversión de Endpoint Clinical y Patient Access para Arsenal Capital Partners
June 05, 2024 16:52 ET | Fortrea Holdings Inc
DURHAM, Carolina del Norte, June 05, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) una organización líder mundial de investigación por contrato (CRO), anunció hoy que finalizó la desinversión de...
Screenshot 2023-07-02 143440.jpg
Fortrea Finaliza Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
June 05, 2024 16:52 ET | Fortrea Holdings Inc
DURHAM, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje que finalizou a alienação dos...
Screenshot 2023-07-02 143440.jpg
Fortrea Melengkapkan Penyahlaburan daripada Perusahaan Endpoint Clinical dan Patient Access kepada Arsenal Capital Partners
June 04, 2024 22:05 ET | Fortrea Holdings Inc
DURHAM, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) Organisasi penyelidikan kontrak global peneraju (“CRO”) hari ini mengumumkan bahawa ia telah melengkapkan penyahlaburan aset...
Screenshot 2023-07-02 143440.jpg
Fortrea Menyelesaikan Divestasi Bisnis Endpoint Clinical dan Patient Access ke Arsenal Capital Partners
June 04, 2024 22:05 ET | Fortrea Holdings Inc
DURHAM, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), sebuah organisasi riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan telah menyelesaikan divestasi aset yang...
Screenshot 2023-07-02 143440.jpg
Fortrea 完成對 Endpoint Clinical 和 Patient Access 業務的剝離,出售予 Arsenal Capital Partners
June 04, 2024 22:05 ET | Fortrea Holdings Inc
北卡羅來納州,達勒姆, June 05, 2024 (GLOBE NEWSWIRE) -- 全球領先的合同研究組織 (「CRO」) Fortrea (Nasdaq: FTRE) 於今日宣布已完成剝離與其支援服務 (Enabling Services) 部門相關的資產,即 Endpoint Clinical (「Endpoint」) 和 Fortrea Patient Access...
Screenshot 2023-07-02 143440.jpg
Fortrea 已将 Endpoint Clinical 和 Patient Access 业务剥离给 Arsenal Capital Partners
June 04, 2024 22:05 ET | Fortrea Holdings Inc
北卡罗来纳州,达勒姆市, June 05, 2024 (GLOBE NEWSWIRE) -- 全球领先的受托研究机构 (“CRO”) Fortrea (纳斯达克代码:FTRE) 今日宣布,已将旗下 Enabling Services 部门,即 Endpoint Clinical (“Endpoint”) 与 Fortrea Patient Access (“FPA”) 业务剥离给...